查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1931157

京冈霉素市场按作物类型、製剂类型、应用方法和最终用途划分，全球预测（2026-2032年）

Jinggangmycin Market by Crop Type, Formulation Type, Application Method, End Use - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，京冈霉素市值将达到 1.3015 亿美元，到 2026 年将成长至 1.3669 亿美元，到 2032 年将达到 1.9003 亿美元，复合年增长率为 5.55%。

关键市场统计数据
基准年 2025 1.3015亿美元
预计年份：2026年 1.3669亿美元
预测年份 2032 1.9003亿美元
复合年增长率 (%) 5.55%

全面介绍京光霉素的农业效用、监管挑战以及推动其在作物保护中广泛应用的科学进展。

京光霉素因其生物来源、靶向定向以及研发机构和商业相关人员的日益关注，在现代作物保护领域占据着独特的地位。京光霉素最初是为防治水稻种植区的真菌病害而开发和应用的，但其在多种作物和农业系统中的广泛适用性引起了人们的关注。日益严格的监管审查和不断发展的管理实践，使得人们越来越需要明确京光霉素的安全使用、残留管理和环境影响等方面的问题。

不断变化的监管、製剂创新和合作研究如何重塑全球京光霉素的应用和管理实践

过去几年，由于监管重新评估、製剂创新以及对综合虫害管理的日益重视，京冈霉素市场格局发生了翻天覆地的变化。主要产区的监管机构加强了残留监测和控制框架，鼓励生产商和经销商投资于合规体系和可靠的分析方法。同时，製剂科学的进步带来了新的给药机制，提高了稳定性，减少了非标靶暴露，并延长了施用期。

评估关税引发的供应链压力因素、采购应对措施以及影响2025年京光霉素生产连续性和供应的韧性策略

近期主要经济体的贸易政策发展和关税措施，为支持活性成分、原料药和农业投入品（例如京光霉素）国际分销的供应链带来了新的复杂性。关税及相关贸易措施会增加采购成本，改变采购偏好，并为依赖跨境原料和包装组件供应的製造商带来时间上的不确定性。因此，进口商和製剂製造商必须重新评估筹资策略和库存缓衝，以确保对生产商和调查计画的持续供应。

细分主导对产品开发、监管文件编制以及作物类型、製剂形式、应用方法和最终用户群等方面的应用策略产生影响

细分市场分析揭示了施用方法、製剂形式、作物类型和最终用户分类如何影响京冈霉素的产品开发重点和推广机制。在考察不同作物类型时，特别是水果蔬菜和水稻，其推广趋势有差异。在水稻种植系统中，京冈霉素历来被优先用于防治纹枯病，并已建立了较为标准化的施用通讯协定。相较之下，水果蔬菜则需要客製化的残留管理、品种相容性测试以及更严格的施用时间，才能达到品质标准。

美洲、欧洲、中东和非洲以及亚太地区的监管差异和农业现状，影响技术的采纳路径和管理重点。

区域趋势将对京光霉素的监管要求、应用模式和商业化路径产生深远影响。在美洲，法规结构强调残留限量、环境风险评估和供应链可追溯性，鼓励製剂生产商采用保守的标籤标註和可靠的分析检验。该地区的生产者网络倾向于强调综合虫害管理（IPM）方法以及在不同气候条件下经证实的疗效，促使企业与当地农业推广服务机构合作开发管理材料。

竞争定位、伙伴关係模式和能力差异化因素决定了参与京冈霉素研发、配製和分销的相关人员。

京冈霉素相关产品的研发竞争格局复杂多样，既有专业生物农药製剂生产商，也有探索佐剂组合的合成化学公司，还有致力于应用科学研究的科研机构。主要参与者正着力透过提高製剂稳定性、减少残留和加强生产品管来实现差异化，同时也投资准备各监管机构要求的资料包。私人企业与学术机构之间的伙伴关係对于建立产品功效和安全性证据基础至关重要，而这些证据对于产品的广泛应用至关重要。

为加强供应链、提升製剂性能、建立制度化管理机制，加速井冈霉素的负责任引进，经营团队可采取切实可行的策略措施。

产业领导者应采取协作策略，在短期业务永续营运与产品管理和配方科学方面的长期创新之间取得平衡。首先，优先考虑供应商多角化和加强品质保证可以降低跨境贸易中断和原物料价格波动带来的风险。投资于替代采购管道并对二级供应商进行资格认证，将确保生产连续性，同时保持合规性。

基于严谨的多源调查方法，结合专家访谈、实地测试、监管审查和基于情境的供应链分析，得出可操作的洞见。

本分析的调查方法结合了多学科证据，以确保获得可靠的实务知识。关键资讯来自对农艺师、製剂科学家、监管专家和商业种植者的结构化访谈，涵盖了不同的操作观点。田间试验观察和对照试验报告为探讨施用方法的有效性和残留问题提供了实证依据，而技术文件和同行评审文献则有助于评估活性成分的行为和製剂间的相互作用。

需要整合并协调技术、监管和营运要求，以实现京光霉素在作物系统中的负责任、有效和永续应用。

总之，儘管京光霉素在某些作物系统中仍是一种有效的病害防治工具，但其未来的推广应用将取决于製剂技术的协同进步、监管的统一性以及供应链的韧性。相关人员必须应对多重压力，包括日益严格的监管、不断发展的应用技术以及影响原材料供应和成本结构的贸易趋势。农业研究和製剂科学正在拓展该产品的效用，但负责任的管理和在地化的经验数据对于其长期持续应用仍然至关重要。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 依作物类型分類的京冈霉素市场

  • 水果和蔬菜
  • 米

9. 京冈霉素市场按剂型类型划分

  • 乳化浓缩液
  • 水分散性颗粒
  • 可湿性粉

第十章 京冈霉素市场依应用领域划分

  • 叶面喷布
  • 种子处理
  • 土壤灌溉

第十一章 京冈霉素市场依最终用途划分

  • 商业农场
    • 大型农场
    • 小规模农场
  • 研究所

第十二章 京冈霉素市场区域划分

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 京冈霉素市场（依集团划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 各国京冈霉素市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

15. 美国井冈霉素市场

第十六章：中国井冈霉素市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Anhui Hualong Technology Co., Ltd.
  • BASF SE
  • Guangdong Huijin Chuan Biological Technology Co., Ltd.
  • Hubei Daonuo Bioengineering Co., Ltd.
  • Hubei Zhengyang Biological Technology Co., Ltd.
  • Jiangsu Woyuan Bioengineering Co., Ltd.
  • Qingdao Kangyuan Bioengineering Co., Ltd.
  • Shandong Lvfeng Bioengineering Co., Ltd.
  • Syngenta AG
  • Zhejiang Yunnan Biotech Co., Ltd.
Product Code: MRR-7B550E008D89

The Jinggangmycin Market was valued at USD 130.15 million in 2025 and is projected to grow to USD 136.69 million in 2026, with a CAGR of 5.55%, reaching USD 190.03 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 130.15 million
Estimated Year [2026] USD 136.69 million
Forecast Year [2032] USD 190.03 million
CAGR (%) 5.55%

Comprehensive context on jinggangmycin's agronomic utility, regulatory pressure points, and the scientific advances shaping adoption across crop protection landscapes

Jinggangmycin occupies a unique position in contemporary crop protection due to its biological origin, targeted efficacy, and growing interest among research and commercial stakeholders. Initially developed and adopted within rice-producing regions to combat fungal diseases, the compound has attracted attention for its broader applicability across diverse crops and farming systems. Regulatory scrutiny and evolving stewardship practices have elevated the need for clarity around safe use, residue management, and environmental considerations.

This report synthesizes technical performance data, formulation developments, supply chain dynamics, and stakeholder behavior to provide a cohesive introduction to jinggangmycin's role in modern agriculture. The introduction establishes the scientific basis of the molecule and contextualizes recent advances in production methods, which have improved consistency and enabled new formulation formats. It also highlights the interplay between agronomic need and product development, showing how growers and researchers are jointly driving innovation.

As adoption patterns shift, decision-makers must reconcile crop protection efficacy with regulatory compliance and market access. Consequently, this section frames the core issues that follow: regulatory momentum, formulation innovation, application practices, and the economic levers that influence adoption across farm types and research institutions. By setting this foundation, stakeholders can better interpret subsequent analyses and translate insights into practical strategies.

How evolving regulatory scrutiny, formulation breakthroughs, and collaborative research are reshaping jinggangmycin deployment and stewardship practices globally

Over the past several years, the landscape around jinggangmycin has undergone transformative shifts driven by regulatory reevaluation, formulation innovation, and an increased emphasis on integrated pest management. Regulatory agencies in key producing regions have intensified residue monitoring and stewardship frameworks, prompting manufacturers and distributors to invest in compliance systems and robust analytical methods. Concurrently, advances in formulation science have delivered new delivery mechanisms that improved stability, reduced non-target exposure, and expanded application windows.

These changes have accelerated collaboration between academia and industry, with field trials designed to quantify efficacy under diverse climatic and agronomic conditions. As a result, growers have begun to refine application timing and integrate the product more deliberately into resistance management plans. At the same time, supply chain actors have responded by optimizing production processes to support varied formulation demands, which in turn has influenced distribution strategies and inventory management.

Taken together, these shifts are moving the sector toward more evidence-driven deployment of jinggangmycin, where data from targeted trials and regulatory compliance requirements shape commercial decisions. The trajectory suggests continued maturation of best practices as stakeholders align on safe, effective, and sustainable use models that reduce environmental impact while maintaining crop protection outcomes.

Assessment of tariff-driven supply chain stressors, sourcing responses, and resilience strategies that influence production continuity and access to jinggangmycin in 2025

Recent trade policy developments and tariff measures implemented by major economies have introduced new complexities into the supply chains that underpin active ingredient availability, formulation inputs, and international distribution of agricultural inputs such as jinggangmycin. Tariffs and related trade measures raise procurement costs, shift sourcing preferences, and can create timing uncertainties for manufacturers reliant on cross-border supply of raw materials and packaging components. Importers and formulators must therefore reassess sourcing strategies and inventory buffers to maintain continuity of supply to growers and research programs.

At the operational level, increased trade frictions have incentivized local sourcing and nearshoring of key feedstocks when feasible, prompting investment in domestic manufacturing capabilities and alternative supplier relationships. These adaptive measures can improve resilience but often require capital expenditure, longer qualification cycles for new suppliers, and updated quality assurance protocols. For research institutions and commercial farms, the immediate effect has been a heightened focus on procurement planning and scenario analysis to account for potential cost volatility and lead-time fluctuations.

Looking ahead, stakeholders will need to balance short-term operational adjustments with strategic investments in supply chain diversification and quality governance. By anticipating tariff-driven pressures and instituting robust supplier qualification processes, organizations can mitigate disruption and maintain access to critical crop protection tools while protecting product integrity and regulatory compliance.

Segment-driven implications for product development, regulatory dossiers, and adoption strategies spanning crop types, formulation formats, application methods, and end-user profiles

Segmentation-driven insights reveal how application, formulation, crop type, and end-user categorization influence product development priorities and adoption mechanisms for jinggangmycin. When considered by crop type - specifically fruits and vegetables versus rice - adoption dynamics diverge: rice systems historically prioritized jinggangmycin for sheath blight control and have more standardized application protocols, whereas fruits and vegetables require tailored residue management, varietal compatibility testing, and narrower application timings to meet quality standards.

Formulation type is another critical determinant; emulsifiable concentrates, water dispersible granules, and wettable powders each present distinct handling, stability, and efficacy profiles that affect grower preference and regulatory submission requirements. Emulsifiable concentrates can offer rapid uptake but may raise formulation management concerns, while water dispersible granules and wettable powders can simplify transport and reduce spill risk but necessitate validation of dispersion characteristics.

Application method also shapes operational adoption: foliar spray, seed treatment, and soil drench each demand different dosing paradigms, equipment configurations, and timing relative to crop phenology. These methods drive how extension services and agronomists craft use recommendations. End use categorization further refines insight; commercial farms and research institutions exhibit different procurement cycles and evidence needs, and within commercial farms the distinction between large-scale and small-scale operations influences purchasing power, application infrastructure, and risk tolerance. Integrating these segmentation dimensions helps stakeholders prioritize formulation R&D, regulatory engagement, and tailored extension services to match real-world use cases.

Regional regulatory diversity and agronomic realities across the Americas, Europe Middle East & Africa, and Asia-Pacific that shape adoption pathways and stewardship priorities

Regional dynamics exert a profound influence on regulatory expectations, adoption patterns, and the commercial pathways for jinggangmycin. In the Americas, regulatory frameworks emphasize residue limits, environmental risk assessment, and supply chain traceability, which encourages formulators to adopt conservative labeling and robust analytical validation. Grower networks in this region often value integrated pest management approaches and documented efficacy under variable climatic conditions, prompting companies to align stewardship materials with local extension services.

Across Europe, Middle East & Africa, regulatory complexity varies considerably, from stringent approvals and public transparency in many European jurisdictions to uneven enforcement and infrastructure constraints in other parts of the region. This heterogeneity requires a flexible approach to dossier preparation, localized field data generation, and tailored risk communication strategies. In parallel, capacity-building initiatives that support safe use and monitoring can accelerate responsible adoption.

The Asia-Pacific region remains a core adopter base where historical usage patterns and agronomic familiarity support broader acceptance, particularly in rice systems. However, emerging regulatory harmonization efforts and consumer preferences for residue minimization are driving reformulation and refined application practices. Manufacturers and research organizations operating across these geographies must therefore calibrate regulatory submissions, field trial strategies, and commercial positioning to account for divergent compliance regimes, infrastructure realities, and grower priorities.

Competitive positioning, partnership models, and capability differentiators that define stakeholders engaged in jinggangmycin development, formulation, and distribution

Competitive landscapes for jinggangmycin-related development encompass a mix of specialized biopesticide formulators, synthetic chemistry firms exploring adjuvant pairings, and research institutions advancing application science. Leading actors concentrate on differentiating through formulation stability, residue mitigation, and production quality management, while also investing in data packages required by diverse regulatory authorities. Partnerships between private developers and academic groups remain central to building the efficacy and safety evidence base needed for broader adoption.

Intellectual property strategies vary by actor; some companies focus on proprietary manufacturing processes and formulation patents to secure commercial advantage, while others emphasize open scientific collaboration to accelerate validation across multiple crop systems. Distribution and channel strategies likewise differ, with some organizations prioritizing direct engagement with large commercial farm networks and others focusing on building relationships with agro-input distributors and extension services that serve smallholder operators. Across the board, transparency in quality controls, traceability of raw materials, and adherence to international best practices are increasingly viewed as competitive differentiators that can ease regulatory interactions and build trust with end users.

For stakeholders evaluating partnerships or competitive positioning, the key considerations include formulation performance, supply chain robustness, and the ability to generate regionally relevant data that supports safe, effective deployment across the intended crop and application contexts.

Practical strategic moves for executives to shore up supply chains, advance formulation performance, and institutionalize stewardship to accelerate responsible jinggangmycin adoption

Industry leaders should pursue a coordinated strategy that balances near-term operational resilience with long-term innovation in product stewardship and formulation science. First, prioritizing supplier diversification and enhanced quality assurance will reduce exposure to cross-border trade disruptions and input variability. Investing in alternative sourcing pathways and qualifying secondary suppliers can preserve production continuity while maintaining regulatory compliance.

Second, leaders should accelerate investment in formulation optimization that targets reduced non-target exposure and improved handling characteristics. By advancing emulsifiable concentrates, water dispersible granules, and wettable powders with demonstrable improvements in stability and efficacy, organizations can better align product attributes with end-user application capabilities. Third, establishing robust field trial networks that generate region-specific efficacy and residue data will streamline regulatory engagement and support targeted extension efforts. Collaborative trials with research institutions and commercial farms of different scales will create the localized evidence needed to inform safe use guidelines.

Finally, companies should adopt transparent communication strategies that educate users on integrated pest management integration, application timing, and resistance mitigation. By combining operational risk management with proactive R&D and stakeholder engagement, industry leaders can protect supply chains, accelerate responsible adoption, and unlock sustainable value from jinggangmycin deployment.

Rigorous multi-source methodology integrating expert interviews, field trials, regulatory review, and scenario-based supply chain analysis to underpin actionable findings

The research methodology underpinning this analysis combined a multi-disciplinary evidence base designed to ensure robust, actionable findings. Primary information was sourced from structured interviews with agronomists, formulation scientists, regulatory experts, and commercial growers to capture diverse operational perspectives. Field performance observations and controlled trial reports provided empirical context for application method efficacy and residue considerations, while technical dossiers and peer-reviewed literature informed assessments of active ingredient behavior and formulation interactions.

Analytical methods included cross-validation of interview insights against documented trial outcomes and regulatory guidance to identify consistent patterns and actionable implications. Supply chain analysis employed a scenario-based approach to evaluate sourcing sensitivities, manufacturing constraints, and distribution dependencies. Throughout the research process, particular attention was paid to ensuring regional representativeness, so that findings reflect distinct regulatory environments and agronomic practices across major geographies.

Quality control measures included triangulation of independent data sources, expert peer review of technical conclusions, and an audit trail for key evidence inputs. This methodological rigor supports the credibility of the insights and facilitates practical translation of findings into policy, commercial, and operational actions.

Synthesis of technical, regulatory, and operational imperatives that must align to enable responsible, effective, and sustainable jinggangmycin deployment across crop systems

In conclusion, jinggangmycin continues to present a valuable tool for targeted disease management across specific crop systems, but its future deployment will depend on coordinated advances in formulation, regulatory alignment, and supply chain resilience. Stakeholders must navigate a confluence of pressures: heightened regulatory scrutiny, evolving application practices, and trade dynamics that influence raw material availability and cost structures. While agricultural research and formulation science are extending the product's utility, responsible stewardship and regionally tailored evidence remain essential to sustaining long-term acceptance.

To capitalize on technical progress, manufacturers and distributors must focus on building robust quality systems, diversifying supply channels, and generating the localized data that regulators and growers require. At the same time, extension services and research institutions will play a pivotal role in translating trial results into practical use recommendations that protect both crop productivity and environmental health. When these elements are combined-sound science, resilient sourcing, and clear stewardship-jinggangmycin can be integrated responsibly into integrated pest management strategies that meet agronomic needs while addressing regulatory and market expectations.

The path forward requires deliberate coordination across industry, research, and regulatory stakeholders to ensure that technical innovation translates into safe, effective, and sustainable crop protection outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Jinggangmycin Market, by Crop Type

  • 8.1. Fruits & Vegetables
  • 8.2. Rice

9. Jinggangmycin Market, by Formulation Type

  • 9.1. Emulsifiable Concentrate
  • 9.2. Water Dispersible Granules
  • 9.3. Wettable Powder

10. Jinggangmycin Market, by Application Method

  • 10.1. Foliar Spray
  • 10.2. Seed Treatment
  • 10.3. Soil Drench

11. Jinggangmycin Market, by End Use

  • 11.1. Commercial Farms
    • 11.1.1. Large-Scale Farms
    • 11.1.2. Small-Scale Farms
  • 11.2. Research Institutions

12. Jinggangmycin Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Jinggangmycin Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Jinggangmycin Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Jinggangmycin Market

16. China Jinggangmycin Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Anhui Hualong Technology Co., Ltd.
  • 17.6. BASF SE
  • 17.7. Guangdong Huijin Chuan Biological Technology Co., Ltd.
  • 17.8. Hubei Daonuo Bioengineering Co., Ltd.
  • 17.9. Hubei Zhengyang Biological Technology Co., Ltd.
  • 17.10. Jiangsu Woyuan Bioengineering Co., Ltd.
  • 17.11. Qingdao Kangyuan Bioengineering Co., Ltd.
  • 17.12. Shandong Lvfeng Bioengineering Co., Ltd.
  • 17.13. Syngenta AG
  • 17.14. Zhejiang Yunnan Biotech Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL JINGGANGMYCIN MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL JINGGANGMYCIN MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL JINGGANGMYCIN MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL JINGGANGMYCIN MARKET SIZE, BY CROP TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL JINGGANGMYCIN MARKET SIZE, BY FORMULATION TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL JINGGANGMYCIN MARKET SIZE, BY APPLICATION METHOD, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL JINGGANGMYCIN MARKET SIZE, BY END USE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL JINGGANGMYCIN MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL JINGGANGMYCIN MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL JINGGANGMYCIN MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES JINGGANGMYCIN MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA JINGGANGMYCIN MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL JINGGANGMYCIN MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL JINGGANGMYCIN MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL JINGGANGMYCIN MARKET SIZE, BY FRUITS & VEGETABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL JINGGANGMYCIN MARKET SIZE, BY FRUITS & VEGETABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL JINGGANGMYCIN MARKET SIZE, BY FRUITS & VEGETABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL JINGGANGMYCIN MARKET SIZE, BY RICE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL JINGGANGMYCIN MARKET SIZE, BY RICE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL JINGGANGMYCIN MARKET SIZE, BY RICE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL JINGGANGMYCIN MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL JINGGANGMYCIN MARKET SIZE, BY EMULSIFIABLE CONCENTRATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL JINGGANGMYCIN MARKET SIZE, BY EMULSIFIABLE CONCENTRATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL JINGGANGMYCIN MARKET SIZE, BY EMULSIFIABLE CONCENTRATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL JINGGANGMYCIN MARKET SIZE, BY WATER DISPERSIBLE GRANULES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL JINGGANGMYCIN MARKET SIZE, BY WATER DISPERSIBLE GRANULES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL JINGGANGMYCIN MARKET SIZE, BY WATER DISPERSIBLE GRANULES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL JINGGANGMYCIN MARKET SIZE, BY WETTABLE POWDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL JINGGANGMYCIN MARKET SIZE, BY WETTABLE POWDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL JINGGANGMYCIN MARKET SIZE, BY WETTABLE POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL JINGGANGMYCIN MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL JINGGANGMYCIN MARKET SIZE, BY FOLIAR SPRAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL JINGGANGMYCIN MARKET SIZE, BY FOLIAR SPRAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL JINGGANGMYCIN MARKET SIZE, BY FOLIAR SPRAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL JINGGANGMYCIN MARKET SIZE, BY SEED TREATMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL JINGGANGMYCIN MARKET SIZE, BY SEED TREATMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL JINGGANGMYCIN MARKET SIZE, BY SEED TREATMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL JINGGANGMYCIN MARKET SIZE, BY SOIL DRENCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL JINGGANGMYCIN MARKET SIZE, BY SOIL DRENCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL JINGGANGMYCIN MARKET SIZE, BY SOIL DRENCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL JINGGANGMYCIN MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL JINGGANGMYCIN MARKET SIZE, BY COMMERCIAL FARMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL JINGGANGMYCIN MARKET SIZE, BY COMMERCIAL FARMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL JINGGANGMYCIN MARKET SIZE, BY COMMERCIAL FARMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL JINGGANGMYCIN MARKET SIZE, BY COMMERCIAL FARMS, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL JINGGANGMYCIN MARKET SIZE, BY LARGE-SCALE FARMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL JINGGANGMYCIN MARKET SIZE, BY LARGE-SCALE FARMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL JINGGANGMYCIN MARKET SIZE, BY LARGE-SCALE FARMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL JINGGANGMYCIN MARKET SIZE, BY SMALL-SCALE FARMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL JINGGANGMYCIN MARKET SIZE, BY SMALL-SCALE FARMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL JINGGANGMYCIN MARKET SIZE, BY SMALL-SCALE FARMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL JINGGANGMYCIN MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL JINGGANGMYCIN MARKET SIZE, BY RESEARCH INSTITUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL JINGGANGMYCIN MARKET SIZE, BY RESEARCH INSTITUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL JINGGANGMYCIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. AMERICAS JINGGANGMYCIN MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 45. AMERICAS JINGGANGMYCIN MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 46. AMERICAS JINGGANGMYCIN MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 47. AMERICAS JINGGANGMYCIN MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 48. AMERICAS JINGGANGMYCIN MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 49. AMERICAS JINGGANGMYCIN MARKET SIZE, BY COMMERCIAL FARMS, 2018-2032 (USD MILLION)
  • TABLE 50. NORTH AMERICA JINGGANGMYCIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. NORTH AMERICA JINGGANGMYCIN MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 52. NORTH AMERICA JINGGANGMYCIN MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 53. NORTH AMERICA JINGGANGMYCIN MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 54. NORTH AMERICA JINGGANGMYCIN MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 55. NORTH AMERICA JINGGANGMYCIN MARKET SIZE, BY COMMERCIAL FARMS, 2018-2032 (USD MILLION)
  • TABLE 56. LATIN AMERICA JINGGANGMYCIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. LATIN AMERICA JINGGANGMYCIN MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 58. LATIN AMERICA JINGGANGMYCIN MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 59. LATIN AMERICA JINGGANGMYCIN MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 60. LATIN AMERICA JINGGANGMYCIN MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 61. LATIN AMERICA JINGGANGMYCIN MARKET SIZE, BY COMMERCIAL FARMS, 2018-2032 (USD MILLION)
  • TABLE 62. EUROPE, MIDDLE EAST & AFRICA JINGGANGMYCIN MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 63. EUROPE, MIDDLE EAST & AFRICA JINGGANGMYCIN MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 64. EUROPE, MIDDLE EAST & AFRICA JINGGANGMYCIN MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 65. EUROPE, MIDDLE EAST & AFRICA JINGGANGMYCIN MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 66. EUROPE, MIDDLE EAST & AFRICA JINGGANGMYCIN MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 67. EUROPE, MIDDLE EAST & AFRICA JINGGANGMYCIN MARKET SIZE, BY COMMERCIAL FARMS, 2018-2032 (USD MILLION)
  • TABLE 68. EUROPE JINGGANGMYCIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. EUROPE JINGGANGMYCIN MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 70. EUROPE JINGGANGMYCIN MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 71. EUROPE JINGGANGMYCIN MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 72. EUROPE JINGGANGMYCIN MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 73. EUROPE JINGGANGMYCIN MARKET SIZE, BY COMMERCIAL FARMS, 2018-2032 (USD MILLION)
  • TABLE 74. MIDDLE EAST JINGGANGMYCIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. MIDDLE EAST JINGGANGMYCIN MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 76. MIDDLE EAST JINGGANGMYCIN MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 77. MIDDLE EAST JINGGANGMYCIN MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 78. MIDDLE EAST JINGGANGMYCIN MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 79. MIDDLE EAST JINGGANGMYCIN MARKET SIZE, BY COMMERCIAL FARMS, 2018-2032 (USD MILLION)
  • TABLE 80. AFRICA JINGGANGMYCIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. AFRICA JINGGANGMYCIN MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 82. AFRICA JINGGANGMYCIN MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 83. AFRICA JINGGANGMYCIN MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 84. AFRICA JINGGANGMYCIN MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 85. AFRICA JINGGANGMYCIN MARKET SIZE, BY COMMERCIAL FARMS, 2018-2032 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC JINGGANGMYCIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC JINGGANGMYCIN MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC JINGGANGMYCIN MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC JINGGANGMYCIN MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC JINGGANGMYCIN MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC JINGGANGMYCIN MARKET SIZE, BY COMMERCIAL FARMS, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL JINGGANGMYCIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. ASEAN JINGGANGMYCIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. ASEAN JINGGANGMYCIN MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 95. ASEAN JINGGANGMYCIN MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 96. ASEAN JINGGANGMYCIN MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 97. ASEAN JINGGANGMYCIN MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 98. ASEAN JINGGANGMYCIN MARKET SIZE, BY COMMERCIAL FARMS, 2018-2032 (USD MILLION)
  • TABLE 99. GCC JINGGANGMYCIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GCC JINGGANGMYCIN MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. GCC JINGGANGMYCIN MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. GCC JINGGANGMYCIN MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 103. GCC JINGGANGMYCIN MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 104. GCC JINGGANGMYCIN MARKET SIZE, BY COMMERCIAL FARMS, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPEAN UNION JINGGANGMYCIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPEAN UNION JINGGANGMYCIN MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPEAN UNION JINGGANGMYCIN MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPEAN UNION JINGGANGMYCIN MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPEAN UNION JINGGANGMYCIN MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPEAN UNION JINGGANGMYCIN MARKET SIZE, BY COMMERCIAL FARMS, 2018-2032 (USD MILLION)
  • TABLE 111. BRICS JINGGANGMYCIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. BRICS JINGGANGMYCIN MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. BRICS JINGGANGMYCIN MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. BRICS JINGGANGMYCIN MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 115. BRICS JINGGANGMYCIN MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 116. BRICS JINGGANGMYCIN MARKET SIZE, BY COMMERCIAL FARMS, 2018-2032 (USD MILLION)
  • TABLE 117. G7 JINGGANGMYCIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. G7 JINGGANGMYCIN MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. G7 JINGGANGMYCIN MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. G7 JINGGANGMYCIN MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 121. G7 JINGGANGMYCIN MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 122. G7 JINGGANGMYCIN MARKET SIZE, BY COMMERCIAL FARMS, 2018-2032 (USD MILLION)
  • TABLE 123. NATO JINGGANGMYCIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. NATO JINGGANGMYCIN MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. NATO JINGGANGMYCIN MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. NATO JINGGANGMYCIN MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 127. NATO JINGGANGMYCIN MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 128. NATO JINGGANGMYCIN MARKET SIZE, BY COMMERCIAL FARMS, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL JINGGANGMYCIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. UNITED STATES JINGGANGMYCIN MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 131. UNITED STATES JINGGANGMYCIN MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. UNITED STATES JINGGANGMYCIN MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. UNITED STATES JINGGANGMYCIN MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 134. UNITED STATES JINGGANGMYCIN MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 135. UNITED STATES JINGGANGMYCIN MARKET SIZE, BY COMMERCIAL FARMS, 2018-2032 (USD MILLION)
  • TABLE 136. CHINA JINGGANGMYCIN MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 137. CHINA JINGGANGMYCIN MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. CHINA JINGGANGMYCIN MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. CHINA JINGGANGMYCIN MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 140. CHINA JINGGANGMYCIN MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 141. CHINA JINGGANGMYCIN MARKET SIZE, BY COMMERCIAL FARMS, 2018-2032 (USD MILLION)